Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors

Hypertension

Volumn 58, Issue 3, 2011, Pages 479-488

  Cat, Aurelie Nguyen Dinh ^a   Briones, Ana M ^a,b   Callera, Glaucia E ^a   Yogi, Alvaro ^a   He, Ying ^a   Montezano, Augusto C ^a   Touyz, Rhian M ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adipocyte secreted factors; corticosteroid receptors; inflammation; vascular smooth muscle cells

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; CASPASE 3; CELL NUCLEUS ANTIGEN; CORTICOSTERONE; EPLERENONE; FIBRONECTIN; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BAX; STRESS ACTIVATED PROTEIN KINASE; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOCYTE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL STRAIN 3T3; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME PHOSPHORYLATION; INFLAMMATION; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

3T3-L1 CELLS; ADIPOCYTES; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CORTICOSTERONE; CULTURE MEDIA, CONDITIONED; FADROZOLE; FIBRONECTINS; HORMONE ANTAGONISTS; MICE; MICE, INBRED C57BL; MIFEPRISTONE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE;

EID: 80051931949     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.168872     Document Type: Article

References (38)

1. Krug AW, Ehrhart-Bornstein M. Newly discovered endocrine functions of white adipose tissue: possible relevance in obesity-related diseases. Cell Mol Life Sci. 2005;62:1359-1362. (Pubitemid 40853823)
2. Rajala MW, Scherer PE. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003;144:3765-3773. (Pubitemid 37088727)
3. Yiannikouris F, Gupte M, Putnam K, Cassis L. Adipokines and blood pressure control. Curr Opin Nephrol Hypertens. 2010;19:195-200.
4. Janiak P, Bidouard JP, Cadrouvele C, Poirier B, Gouraud L, Grataloup Y, Pierre F, Bruneval P, O'Connor SE, Herbert JM. Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. Eur J Pharmacol. 2006;534:271-279. (Pubitemid 43384210)
5. Boustany CM, Brown DR, Randall DC, Cassis LA. AT1-receptor antagonism reverses the blood pressure elevation associated with dietinduced obesity. Am J Physiol Regul Integr Comp Physiol. 2005;289: R181-R186. (Pubitemid 40874974)
6. He H, Yang D, Ma L, Luo Z, Ma S, Feng X, Cao T, Yan Z, Liu D, Tepel M, Zhu Z. Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-T-dependent pathways. Hypertension. 2010;55:869-879.
7. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors. Proct Natl Acad Sci USA. 2003;100:14211-14216. (Pubitemid 37499216)
8. Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J. Impact of the obesity on hypertension and renal disease. Current Hypertens Rep. 2003; 5:386-392. (Pubitemid 38898962)
9. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41: 625-633. (Pubitemid 36314565)
10. Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol. 2006;17:3438-3446. (Pubitemid 44865286)
11. Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, Weintraub NL. Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol. 2010;10:191-196.
12. Gao YJ, Lu C, Su LY, Sharma AM, Lee RM. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide, Br J Pharmacol. 2007;151:323-331. (Pubitemid 46842669)
13. Ma L, Ma S, He H, Yang D, Chen X, Luo Z, Liu D, Zhu Z. Perivascular fat-mediated vascular dysfunction and remodeling through the AMPK/mTOR pathway in high-fat diet-induced obese rats. Hypertens Res. 2010;33:446-453.
14. Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res. 2009;81: 370-380.
15. Zhang H, and Zhang C. Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of an adipose-vascular loop. Am J Biomed Sci,. 2009;1:133-142.
16. Callera GE, Touyz RM, Tostes RC, Yogi A, He Y, Malkinson S, Schiffrin EL. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension. 2005;45:773-779. (Pubitemid 40418380)
17. Cascella T, Radhakrishnan Y, Maile LA, Busby WH Jr, Gollahon K, Colao A, Clemmons DR. Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells. Endocrinology. 2010;151:5851-5864.
18. Muto S, Ebata S, Okada K, Saito T, Asano Y. Glucocorticoid modulates Na/H2exchange activity in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int. 2000;57:2319-2333. (Pubitemid 30340731)
19. Briones AM, Nguyen Dinh Cat A, Callera GE, Yogi A, Burger D, He Y, Correa JW, Gagnon AM, Gomez-Sanchez C, Gomez-Sanchez EP, Sorisky A, Burns KD, Touyz RM. Production of aldosterone by adi-pocytes: implications for obesity and vascular function. Hypertension. 2010;56:e74.
20. Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest. 2002;25: 855-861. (Pubitemid 35446352)
21. Weiland F, Verspohl EJ. Local formation of angiotensin peptides with paracrine activity by adipocytes. J Pept Sci. 2009;15:767-776.
22. Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation. 2004;109:2792-2800. (Pubitemid 38737927)
23. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res. 2005;96:643-650. (Pubitemid 40478331)
24. Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, Touyz RM. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redoxsensitive RhoA pathways. Arterioscler Thromb Vasc Biol. 2008;28: 1511-1518.
25. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987;237:268-275. (Pubitemid 17095145)
26. Molnar GA, Lindschau C, Dubrovska G, Mertens PR, Kirsch T, Quinkler M, Gollasch M, Wresche S, Luft FC, Muller DN, Fiebeler A. Glucocorticoid-related signaling effects in vascular smooth muscle cells. Hypertension. 2008;51:1372-1378. (Pubitemid 351555952)
27. Krug AW, Allenhöfer L, Monticone R, Spinetti G, Gekle M, Wang M, Lakatta EG. Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways. Hypertension. 2010;55:1476-1483.
28. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988; 242:583-585. (Pubitemid 18263202)
29. Lombes M, Kenouch S, Souque A, Farman N, Rafestin-Oblin ME. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11A-hydroxysteroid dehydrogenase. Endocrinology. 1994;135:834-840.
30. Gros R, Ding Q, Sklar LA, Prossnitz EE, Arterburn JB, Chorazyczewski J, Feldman RD. GPR30 expression is required for the mineralocorticoid receptor: independent rapid vascular effects of aldosterone. Hypertension. 2011;57:442-451.
31. Hoppmann J, Perwitz N, Meier B, Fasshauer M, Hadaschik D, Lehnert H, Klein J. The balance between gluco-and mineralo-corticoid action critically determines inflammatory adipocyte responses. J Endocrinol. 2010; 204:153-164.
32. Ma J, Albornoz F, Yu C, Byrne DW, Vaughan DE, Brown NJ. Differing effects of mineralocorticoid receptor-dependent and-independent potassium-sparing diuretics on fibrinolytic balance. Hypertension. 2005; 46:313-320. (Pubitemid 41099163)
33. Caprio M, Newfell BG, la Sala A, Baur W, Fabbri A, Rosano G, Mendelsohn ME, Jaffe IZ. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res. 2008; 102:1359-1367.
34. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2002;283:H1802-H1810. (Pubitemid 35217013)
35. Miao CY, Li ZY. The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol. Epub ahead of print April 6, 2011. DOI: 10.1111/j.1476-5381.2011.01404.x.
36. Hommes DW, Peppelenbosch MP, van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel antiinflammatory targets. Gut. 2003;52:144-151. (Pubitemid 36020783)
37. Muslin AJ. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond). 2008; 115:203-218.
38. Samarakoon R, Higgins PJ. Integration of non-SMAD and SMAD signaling in TGF-β1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. Thromb Haemost. 2008;100: 976-983.